ADIPOSE LIMITED
Opportunity 80/100 (exceptional), bankability 75/100. Same-surname younger director in place — likely family handover, not open to sale. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Cash flow review and working-capital discipline. Cash down -94% YoY — forensic review of receivables, stock turns, and creditor days. Most likely exit: strategic trade sale (73/100).
Data confidence
Overall: medium (79/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Strong composite across quality, acquirability, and risk. High-priority target — progress to serious diligence.
Signals from accounts
Derived from iXBRL accounts · FRS 102Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-03-31 | 2024-03-31 |
|---|---|---|
| Total assets | £134.5k | £695.2k |
| Current assets | £96.3k | £643.7k |
| Cash | £34.9k | £581.1k |
| Debtors | £49.9k | £52.2k |
| Net assets | £134.5k | £695.2k |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 officers
- • 1 confirmation-statement
- • 1 officers
- • 1 confirmation-statement
- • 1 officers
Corporate timeline (23 events)Click to expand
- 2026-05-07📄change-person-director-company-with-change-dateofficers · CH01
- 2025-06-24📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2025-06-04📄memorandum-articlesincorporation · MA
- 2025-06-04📄resolutionresolution · RESOLUTIONS
- 2025-06-03📄capital-name-of-class-of-sharescapital · SH08
- 2025-05-22📄appoint-person-director-company-with-name-dateofficers · AP01
- 2025-05-12📄notification-of-a-person-with-significant-controlpersons-with-significant-control · PSC02
- 2025-05-12📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2025-05-12📄cessation-of-a-person-with-significant-controlpersons-with-significant-control · PSC07
- 2025-03-17➕DARLINGTON, Hannah appointeddirector
- 2024-06-18📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2023-09-12📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-09-12📄change-to-a-person-with-significant-controlpersons-with-significant-control · PSC04
- 2023-06-19📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2022-11-28📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2021-09-13📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2020-07-20📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2019-09-23📄accounts-with-accounts-type-total-exemption-fullaccounts · AA
- 2010-08-18➕DARLINGTON, Andrea Mary appointedsecretary
- 2010-08-18➖DARLINGTON, Andrea Mary resigneddirector
- 2010-05-04🏢Company incorporatedAs ADIPOSE LIMITED
- 2010-05-04➕DARLINGTON, Philip James appointeddirector
- 2010-05-04➕DARLINGTON, Andrea Mary appointeddirector
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
- +Long-tenure founder: Senior director has been in place 16 years — deep operational knowledge concentrated in one person.
- +Senior director age: Director aged approximately 64 — approaching natural succession window.
- +Family involvement: Multiple officers share a surname — likely family business, which concentrates governance.
Succession & seller-readiness
Limited succession signal. Not a near-term off-market candidate.
- primaryFamily succession underway: Not a takeover target — DARLINGTON, Hannah (same surname) appointed 2025-03-17. Pattern consistent with intra-family handover.
- primaryFounder aged 63+: Senior director is approximately 64. Approaching typical UK retirement age — succession thinking likely.
- secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
- secondary12+ year tenure: Director in role 16 years.
- supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.
Red flags
cleanGroup structure
Hld Optical Ltd holds majority control (50-75%). Likely parent but not wholly-owned.
Parent relationships inferred from Persons with Significant Control filings. Full subsidiary tree requires reverse-lookup (coming).
Shareholders & ownership
1 active beneficial owner| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Hld Optical Ltd Corporate entity | 50–75% | — | 50-75% shares | 17/03/2025 |
2 historic (ceased) PSCs
- Mrs Andrea Mary Darlingtonceased 17/03/2025· 25-50% shares · 25-50% voting
- Mr Philip James Darlingtonceased 17/03/2025· 50-75% shares · 50-75% voting
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · CF postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| AA IONESCU LTD→ 10729028 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
| ABLOC HEALTH LTD→ 16104317 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ABSOLUTE BIOMEDICAL LTD→ 13131330 · est 2021 · no financials extracted | — | — | — | — | 5y | — | — |
| ACE FEET IN MOTION LTD→ 09479066 · est 2015 · no financials extracted | — | — | — | — | 11y | — | — |
| ACE SOCIAL WORK LTD→ 11507371 · est 2018 · no financials extracted | — | — | — | — | 7y | — | — |
| ACH LLYNFI LTD→ 17073238 · est 2026 · no financials extracted | — | — | — | — | — | — | — |
| ACORNS NURSERIES LIMITED→ 03023352 · est 1995 · no financials extracted | — | — | — | — | 31y | — | — |
| ACTIVE MOTION CHIROPRACTIC LIMITED→ 16103041 · est 2024 · no financials extracted | — | — | — | — | 1y | — | — |
| ADENPALM LIMITED→ 12994894 · est 2020 · no financials extracted | — | — | — | — | 5y | — | — |
| ADENVIEW LIMITED→ 16872653 · est 2025 · no financials extracted | — | — | — | — | — | — | — |
| ADONCOCAR LTD→ 15142772 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
| ADT CHIROPRACTIC LTD→ 11066385 · est 2017 · no financials extracted | — | — | — | — | 8y | — | — |
6 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (3 active · 1 resigned)
Click a director name to see their full track record across all companies.